Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.33 |
| ▸ | NQO2 | P16083 | 1/20 | 0.32 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.32 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | HTR4 | Q13639 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6404087 | 0.84 | OPRM1 (0.37) | FFAR4CHRNA7 | |
| SCHEMBL5069022 | 0.80 | LMNA (0.31) | — | |
| SCHEMBL6397641 | 0.75 | POLB (0.42) | CHRNA7ACHEHTR4 | |
| SCHEMBL6399842 | 0.74 | HDAC3 (0.33) | FFAR4CHRNA7NQO2MTNR1AMTNR1B | |
| SCHEMBL6400747 | 0.72 | ALDH1A1 (0.38) | ACHEHTR4 | |
| SCHEMBL6400263 | 0.71 | ALDH1A1 (0.33) | — | |
| SCHEMBL6399843 | 0.70 | PTGDR2 (0.32) | ACHEHTR4 | |
| SCHEMBL26698382 | 0.69 | OPRM1 (0.38) | — | |
| SCHEMBL20808413 | 0.65 | OPRM1 (0.35) | — | |
| SCHEMBL20797235 | 0.65 | OPRM1 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1245660-B1 | Liquid crystal compounds having bis(trifluoromethyl)phenyl rings, liquid crystal compositions and liquid crystal display devices | CHISSO CORP (JP) | 2005-02-23 | — | — | EP | disclosed |
| US-6844032-B2 | Liquid crystal compounds having bis(trifluoromethyl) phenyl rings, liquid crystal compositions and liquid crystal display devices | CHISSO CORPORATION (JP) | 2005-01-18 | — | — | US | disclosed |
| US-20030077405-A1 | Liquid crystal compounds having bis(trifluoromethyl) phenyl rings, liquid crystal compositions and liquid crystal display devices | JNC PETROCHEMICAL CORPORATION (JP) | 2003-04-24 | — | — | US | disclosed |
| EP-1245660-A2 | Liquid crystal compounds having bis(trifluoromethyl)phenyl rings, liquid crystal compositions and liquid crystal display devices | CHISSO CORPORATION (JP) | 2002-10-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030077405-A1 | Liquid crystal compounds having bis(trifluoromethyl) phenyl rings, liquid crystal compositions and liquid crystal display devices | RCC1, KCNH2, OCIAD2 | FFAR4 2403/4885CHRNA7 1202/4885NQO2 398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.